Cargando…
The Managing Cancer and Living Meaningfully (CALM) Intervention Alleviates Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer by Modulating Pan-Immune-Inflammation Values
BACKGROUND: The number of patients with breast cancer is increasing worldwide, resulting in a growing number of patients with chemotherapy-related cognitive impairment (CRCI), which seriously affects their quality of life. CRCI is associated with inflammatory factors and systemic inflammatory marker...
Autores principales: | Yao, Senbang, Ding, Ke, Liu, Shaochun, Zhang, Qianqian, Li, Wen, Tang, Lingxue, Yu, Sheng, Pang, Lulian, Yin, Xiangxiang, Cheng, Huaidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703526/ https://www.ncbi.nlm.nih.gov/pubmed/36419389 http://dx.doi.org/10.1177/15347354221140498 |
Ejemplares similares
-
Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting‐state fMRI
por: Yao, Senbang, et al.
Publicado: (2023) -
Re: Response to In regard to Ding et al. 2020: “Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy Related Cognitive Impairment in Breast Cancer Survivors”
por: Cheng, Huaidong, et al.
Publicado: (2023) -
Impact of the CALM intervention on breast cancer patients during the COVID-19 pandemic
por: Pang, Lulian, et al.
Publicado: (2023) -
Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors
por: Ding, Ke, et al.
Publicado: (2020) -
Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy‐related cognitive impairment in patients with breast cancer who receive chemotherapy
por: Yao, Senbang, et al.
Publicado: (2022)